Analyst Ratings

Upgrades, downgrades, and price-target changes from Wall Street firms.

Get trade alerts by text

We text you when insiders, Congress or big funds make new trades. Free.

UBS Reiterates Buy Rating on Expand Energy Corporation

UBS has reaffirmed a Buy rating on Expand Energy Corporation with a new price target of $120.

$EXE

Barclays Reiterates Underweight Rating on Dow Inc.

Barclays has reiterated its Underweight rating for Dow Inc., setting a target price of $30.00.

$DOW

Guggenheim Maintains Buy Rating on Tenet Healthcare

Guggenheim has reaffirmed its Buy rating for Tenet Healthcare Corporation with a price target increase.

$THC

RBC Capital Reiterates Underperform Rating on Amrize Ltd

RBC Capital has maintained its Underperform rating on Amrize Ltd, lowering its price target to $32.0 on October 9, 2026.

$AMRZ

Longbow Research Reiterates Buy Rating on Amrize Ltd

Longbow Research has reaffirmed its Buy rating on Amrize Ltd as of October 12, 2026, while the stock trades at $37.77.

$AMRZ

Truist Securities Reiterates Buy Rating on Packaging Corporation of America

Truist Securities has reaffirmed its Buy rating on Packaging Corporation of America with a revised price target of $280.

$PKG

Citizens Reiterates Market Outperform Rating on Brown & Brown, Inc.

Citizens maintains its Market Outperform rating on Brown & Brown, setting a price target of $75 as the stock trades below this level.

$BRO

TD Cowen Reiterates Buy Rating on Brown & Brown, Inc.

TD Cowen has reiterated its Buy rating on Brown & Brown with a price target of $82.

$BRO

RBC Capital Raises Price Target on Casey's General Stores, Inc.

RBC Capital upgraded Casey's target price as the stock trades below the new estimate.

$CASY

JP Morgan Reiterates Overweight Rating on Bunge Global SA

JP Morgan continues to endorse Bunge Global SA with an Overweight rating and a price target of $139.

$BG

Barclays Reiterates Overweight Rating on Entegris, Inc. (ENTG)

Barclays maintains its Overweight rating on Entegris, Inc. with a target price of $212, indicating strong growth potential.

$ENTG

Truist Securities Reiterates Buy Rating on Entegris, Inc.

Truist Securities has reiterated its Buy rating on Entegris with a $190 price target on October 14, 2026.

$ENTG

Wells Fargo Reiterates Overweight Rating on Tradeweb Markets Inc.

Wells Fargo has reiterated its Overweight rating and raised the price target for Tradeweb Markets to $125.

$TW

JP Morgan Reiterates Underweight Rating on T. Rowe Price

JP Morgan has reiterated its Underweight rating on T. Rowe Price with a new price target of $106.

$TROW

Barclays Reiterates Underweight Rating on T. Rowe Price Group, Inc.

Barclays has reiterated its Underweight rating on T. Rowe Price with a reduced price target.

$TROW

BMO Capital Reiterates Outperform Rating on Verisk Analytics

BMO Capital has reaffirmed its Outperform rating on Verisk Analytics with a new price target of $217.

$VRSK

TD Cowen Maintains Buy Rating on AerCap Holdings N.V. with $185 Target

TD Cowen has reiterated its Buy rating on AerCap Holdings N.V. and raised its price target to $185.

$AER

Barclays Reiterates Overweight Rating on PPG Industries

Barclays maintains its Overweight rating on PPG Industries with a new price target of $136.

$PPG

Morgan Stanley Reiterates Overweight Rating on Guardant Health

Morgan Stanley has reiterated its Overweight rating on Guardant Health with a new price target of $200.

$GH

Truist Securities Maintains Buy Rating on Smurfit Westrock

Truist Securities has reiterated its Buy rating on Smurfit Westrock with a new price target of $54.

$SW

RBC Capital Maintains Outperform Rating on Smurfit Westrock

RBC Capital reaffirms its positive outlook on Smurfit Westrock with a price target reduction.

$SW

Mizuho Maintains Outperform Rating on Hubbell Incorporated (HUBB)

Mizuho has reiterated its Outperform rating on Hubbell, adjusting its price target down to $560 from $575.

$HUBB

Susquehanna Reiterates Positive Rating on Formula One Group

Susquehanna keeps its Positive rating on Formula One Group, lowering the price target to $110.

$FWONK

Canaccord Genuity Maintains Buy Rating on BioNTech SE

Canaccord Genuity has reiterated its Buy rating on BioNTech SE with a new price target of $132.

$BNTX

Get trade alerts by text